FTV$55.51
$56.02
Chart
Performance
Key Stats
AI FTV Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
NeutralFortive Corporation (FTV) presents a mixed investment profile. Fundamentally, it demonstrates solid profitability and a stable financial position. However, recent performance has been negative, and technical indicators suggest a cautious short-term outlook. The company operates in sectors with potential for growth but faces some headwinds.
Thematic
Fortive operates in industrial technology and healthcare solutions, areas with moderate thematic tailwinds. Its focus on intelligent operating solutions and advanced healthcare solutions aligns with trends in industrial automation, digitalization, and healthcare efficiency.
Fundamental
Fortive demonstrates a solid financial foundation with consistent profitability and revenue growth over recent years. Its balance sheet is managed prudently, and it generates healthy free cash flow. The valuation appears reasonable given its historical performance and industry position.
Technical
Fortive's stock price has experienced a recent downturn, trading below key moving averages. While support levels exist, the short-term trend is bearish, with most technical indicators suggesting selling pressure.
| Factor | Score |
|---|---|
| Industrial Automation & Digitalization | 70 |
| Healthcare Efficiency & Technology | 75 |
| Supply Chain Resilience | 60 |
| Regulatory Environment (Healthcare) | 50 |
| Geographic Diversification | 70 |
| Factor | Score |
|---|---|
| Valuation | 70 |
| Profitability | 75 |
| Growth | 60 |
| Balance Sheet Health | 80 |
| Cash Flow | 85 |
| Dividend Yield | 40 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 40 |
| Volume Confirmation | 50 |
| Support & Resistance | 70 |
| Oscillator Summary | 60 |
AI Investing Checklist
Powered by LiveAIBullish Points (7)
Consistent EPS Beat
The company has exceeded earnings per share (EPS) estimates in the last five reported quarters, with an average surprise of 3.4%. This consistent outperformance indicates strong operational execution and effective management.
Undervalued Growth Potential
The Price/Earnings (P/E) TTM ratio is 22.39, which is lower than the industry average of 25.0. Combined with a projected earnings growth rate, this suggests the stock may be undervalued relative to its peers and future growth prospects.
Bearish Points (7)
Elevated P/S Ratio
The trailing Price-to-Sales (P/S) ratio of 3.7 is higher than its 2023 P/S ratio of 2.9, indicating that the market is valuing each dollar of sales more highly, potentially suggesting it's becoming less attractive from a sales multiple perspective.
Slowing Revenue Growth (QoQ)
While annual revenue growth is positive, the quarterly revenue for Q1 2025 ($1.47B) is lower than Q4 2024 ($1.62B), indicating a sequential slowdown in top-line growth.
Calendar
May 2025
30
Ex-Dividend Date
June 2025
27
Next Dividend Date
July 2025
30
Next Earnings Date
H: $0.62
A: $0.61
L: $0.58
H: 1.06B
A: 1.03B
L: 997.00M
Profile
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Seasonals
Price Target
79.10 USD
The 39 analysts offering 1 year price forecasts for FTV have a max estimate of 116.00 and a min estimate of 51.98.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 100
Fortive was spun off from Danaher in 2016, making it Fortive's direct parent company and a strong historical and strategic peer in diversified science and technology.
Weight: 95
Veralto was also spun off from Danaher (in 2023), holding businesses related to water quality and product identification, sharing a common strategic lineage and some portfolio characteristics with Fortive.
Weight: 90
Roper is a diversified technology company known for its similar strategy of acquiring high-margin, asset-light industrial software and technology businesses, making it a key strategic comparable.
Weight: 88
A leading global provider of industrial automation and information solutions, directly competing with Fortive's automation and controls businesses within the Intelligent Operating Solutions segment.